Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories.
To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
----------------------------------------------
** BREAST CANCER News **
IU Simon Cancer Center's Tissue Bank Collecting Samples Jan. 10
http://www.medicalnewstoday.com/articles/133594.php
Would you like to contribute to breast cancer research? You can help by donating a tissue sample to the Susan G. Komen for the Cure Tissue Bank at the IU Simon Cancer Center from 8:30 a.m. to 2:30 p.
----------------------------------------------
** CANCER / ONCOLOGY News **
Dendrimer Reduces Toxicity Of Cancer Drug
http://www.medicalnewstoday.com/articles/133612.php
Starpharma Holdings Ltd (ASX:SPL)(PINK:SPHRY) reported an important advance in its dendrimer-based drug-delivery program. A Starpharma dendrimer combined with a widely-used cancer drug (doxorubicin) has achieved a significant extension of the drug's plasma half-life and a marked reduction in drug toxicity compared to administration of the drug alone.
New Study Finds Endonasal Surgery Offers Hormonal Benefits For Pituitary Gland Tumor Patients
http://www.medicalnewstoday.com/articles/133606.php
Patients diagnosed with a brain tumor affecting the body's "master gland" have encouraging news: When the tumor is removed using minimally invasive surgery, patients can enjoy a good chance of restoring normal hormonal function and recovering their health.
Cornerstone Pharmaceuticals Announces $6 Million Financing To Further Advance Clinical Trials In Cancer Patients
http://www.medicalnewstoday.com/articles/133597.php
Cornerstone Pharmaceuticals, Inc., a privately-held pharmaceutical company focused on developing drugs in the emerging field of cancer bioenergetics, announced recently that it has raised a minimum of $6 million from a private investor group.
IU Simon Cancer Center's Tissue Bank Collecting Samples Jan. 10
http://www.medicalnewstoday.com/articles/133594.php
Would you like to contribute to breast cancer research? You can help by donating a tissue sample to the Susan G. Komen for the Cure Tissue Bank at the IU Simon Cancer Center from 8:30 a.m. to 2:30 p.
Modified Gene Targets Cancer Cells A Thousand Times More Often Than Healthy Cells
http://www.medicalnewstoday.com/articles/133573.php
Researchers at the University of Rochester have designed a gene that produces a thousand times more protein in cancer cells than in healthy cells.The findings may help address the prime challenge in anti-cancer therapy: improving treatments' ability to specifically and effectively target cancer cells.
6th ESOU Meeting: Updates In Onco-Urology
http://www.medicalnewstoday.com/articles/133553.php
The 6th Meeting of the European Society of Oncological Urology (ESOU) will be held in the Ceylan InterContinentall in Istanbul (TR), from 16 to 18 January 2009, with organisers presenting the latest updates on treatment strategies to onco-urology specialists.
----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **
No news for this category today.
----------------------------------------------
** COLORECTAL CANCER News **
No news for this category today.
----------------------------------------------
** LUNG CANCER News **
No news for this category today.
----------------------------------------------
** LYMPHOMA / LEUKEMIA News **
EpiCept Announces Health Canada's Approval For Ceplene Filing For The Treatment Of Acute Myeloid Leukemia
http://www.medicalnewstoday.com/articles/133547.php
EpiCept Corporation (Nasdaq and OMX Nordic Exchange: EPCT) has announced that, at a recent pre-New Drug Submission (pre-NDS) meeting with representatives of Health Canada, it received permission to proceed with a New Drug Submission (NDS) filing for Ceplene® (histamine dihydrochloride) for the treatment of acute myeloid leukemia (AML) in Canada.
----------------------------------------------
** PROSTATE / PROSTATE CANCER News **
Evaluation Of Treatments For Benign Prostatic Enlargement
http://www.medicalnewstoday.com/articles/133549.php
Research published by the National Institute for Health Research Health Technology Assessment (NIHR HTA) programme has found that transurethral resection, the most common operation for benign prostatic enlargement (BPE), remains a clinically and cost-effective treatment.
-------------------------------------------------------------
You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
No comments:
Post a Comment